The Global Digital Breast Tomosynthesis DBT System Market Size Is Expected To Grow From USD 657.7 Million In 2021 To 2030 At A CAGR Of 5.9%.

Digital Breast Tomosynthesis (DBT) System Market Overview:

Digital breast tomosynthesis (DBT) is an advanced form of breast cancer screening that uses low-dose x-rays to create a three-dimensional (tomosynthesis) image of the breast. The DBT system is also sometimes referred to as "digital tomosynthesis" or "tomography". DBT provides a more comprehensive view of the breast than traditional 2D (digital mammography), making it easier for radiologists to spot subtle abnormalities and cancers. Additionally, DBT helps reduce false positives, which often lead to unnecessary biopsies. The growth of this market can be attributed to the increasing incidence of breast cancer, increasing demand for early diagnosis and treatment of breast cancer, and technological advancements in digital breast tomosynthesis (DBT) systems.

Digital Breast Tomosynthesis (DBT) System market size, estimates and forecasts are provided in terms of sales volume (K units) and revenue (million USD), with historical and forecast data for the period 2017 to 2030, with 2022 being considered as the base year. This report segments the global Digital Breast Tomosynthesis (DBT) System market in detail. Regional market sizes related to products by type, by application, and by player are also delivered. In estimating the size of the market, we took into account the impact of COVID-19 and the Russian-Ukraine war.

Major Segments Covered in the Global Digital Breast Tomosynthesis (DBT) System Market:

Market Key Players:
Hologic, GE Healthcare, Siemens, I.M.S., PLANMED OY, XinRay Systems, FUJIFILM, And Others.

Digital Breast Tomosynthesis (DBT) System Market by Types:

• 2D Digital Mammography Technology, 3D Digital Mammography Technology

Digital Breast Tomosynthesis (DBT) System Market by Applications:

• Hospitals, Diagnostic Centres, Others

Digital Breast Tomosynthesis (DBT) System Market by Regions:

The report estimates revenue growth at the worldwide, regional and country level and delivers analysis of the recent industry trends in each sub-segment from 2017 to 2030.

North America is expected to hold a major market share in the global digital breast tomosynthesis (DBT) devices market owing to high demand for innovative products and increasing adoption of screening methods. Rising prevalence of breast cancer, significant research and development in breast cancer therapies, and advancements in breast imaging modalities are the key drivers for the market in this region. For example, the 2020 International Agency for Research on Cancer reported that about 2.54 million breast cancer cases were reported in the region in 2020, and this number is expected to increase to 3.53 million cases by 2040. Likewise, in January 2022, the American Cancer Society reported that breast cancer is the most common cancer among women in the United States, with 1 in 3 women being diagnosed with breast cancer. The American Cancer Society also estimates that by 2022, women in the United States will report approximately 2,87,850 new cases of invasive breast cancer. Hence, high incidence of breast cancer cases is driving the market in this region.

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
• Germany
• France
• Italy
• Spain
• UK
• Nordic Countries
• Denmark
• Finland
• Iceland
• Sweden
• Norway
• Benelux Union
• Belgium
• The Netherlands
• Luxembourg
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Southeast Asia
• Indonesia
• Thailand
• Malaysia
• Singapore
• Rest of Southeast Asia
• Rest of Asia-Pacific
• The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

Significant Market Dynamics:

Drivers:

Increasing incidence of breast cancer is the major factor driving the growth of the global digital breast tomosynthesis (DBT) devices market during the forecast period. For example, in 2019, women in the United States are expected to be diagnosed with 268,600 new cases of invasive breast cancer and 62,930 new cases of noninvasive (in situ) breast cancer, according to Breastcancer.org.

Increasing awareness about early diagnosis of breast cancer is also expected to aid in the growth of the market. Screening with DBT can improve breast cancer detection rates and reduce recalls—when women are called back for additional testing because of a potentially abnormal finding.

North America dominated the global digital breast tomosynthesis (DBT) devices market with a 55.1% value share in 2019, followed by Europe.

 Restraints:

Lack of evidence regarding the efficacy of DBT is expected to hamper the growth of the global digital breast tomosynthesis (DBT) devices market. No significant trials have been performed on DBT. These trials require large numbers of participants to demonstrate the substantial benefits of DBT in cancer detection.

Furthermore, increase in interpretation time for radiologists is also expected to hamper the growth of the market. Due to the large number of images generated, the time required to read a DBT image set is almost double that of interpreting a 2D mammogram; approximately 200 images compared to four images for a 2D view.

Opportunities:

During DBT, patients are exposed to higher levels of radiation than with 2D mammography. Hence, reduction in radiation exposure is expected to offer lucrative growth opportunities for players in the global digital breast tomosynthesis (DBT) devices market.

Regulators also need to define the use of DBT in breast cancer screening (individual and tissue) and its role in the diagnosis and staging of breast cancer (multiple lesions).

The hospital segment of the global digital breast tomosynthesis (DBT) devices market was valued at USD 968.6 million in 2019 and is expected to reach USD 2,866.8 million by 2027, at a CAGR of 14.5% during the forecast period.

Report Scope of Global Digital Breast Tomosynthesis (DBT) System Market:

Report Attributes	Details
Growth Rate	CAGR of 5.9% from 2022 to 2030.
By Type	2D Digital Mammography Technology, 3D Digital Mammography Technology
By Application	Hospitals, Diagnostic Centres, Others
By Companies	Hologic, GE Healthcare, Siemens, I.M.S., PLANMED OY, XinRay Systems, FUJIFILM
Regions and Countries Covered	North America: (US, Canada, Mexico, Rest of North America) Europe(Germany, France, Italy, Spain, UK, Nordic Countries, Benelux Union, Rest of Europe) Asia-Pacific (Japan, China, India, Australia, South Korea, Southeast Asia, Rest of Asia-Pacific) The Middle East & Africa(Saudi Arabia, UAE, Egypt, South Africa, Rest of the Middle East & Africa) Latin America(Brazil, Argentina, Rest of Latin America) Rest Of the World
Base Year	2022
Historical Year	2017 to 2022
Forecast Year	2023 to 2030

Points Covered in the Report

• The points that are discussed within the report are the major market players that are involved in the Market such as Market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
• The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years of data history and forecast.
• The growth factors of the Market are discussed in detail wherein the different end users of the Market are explained in detail.
• Data and information by Market player, region, type, application and etc., and custom research can be added according to specific requirements.
• The report contains the SWOT analysis of the Market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Frequently Asked Questions-

What is the CAGR of Digital Breast Tomosynthesis (DBT) System market?

The Digital Breast Tomosynthesis (DBT) System Market is growing at a CAGR of 5.9% During Forecast Period.

 What are the key types of Digital Breast Tomosynthesis (DBT) System market?

2D Digital Mammography Technology, 3D Digital Mammography Technology

What are the key applications of Digital Breast Tomosynthesis (DBT) System market?

Hospitals, Diagnostic Centres, Others                                       

Who are the key players in Digital Breast Tomosynthesis (DBT) System market?

Hologic, GE Healthcare, Siemens, I.M.S., PLANMED OY, XinRay Systems, FUJIFILM, And others.

Any special requirements about this report, please let us know and we can provide custom report.

Note – In order to provide a more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19 and the Russia-Ukraine war.